Skip to content
1st Counsel – Lifestyle
Author:
MimiVax, Inc.
MimiVax and Roswell Park Announce Results from Phase 2b SURVIVE Trial of SurVaxM in Newly Diagnosed Glioblastoma
October 7, 2026